0.0650CAD+8.33%Mkt Cap: 6.53M CADP/E: —Last update: 2026-05-25
Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily …
Industry Peers
Diagnostics & Research166.94BUSDP/E 24.7
122.72BUSDP/E 33.6
44.05BUSDP/E 41.1
34.42BCHFP/E 37.9
33.46BUSDP/E 43.3
32.69BUSDP/E 25.5
28.46BUSD—
27.28BUSDP/E 20.3
Indicators:|
Key Statistics
Company
Market Cap6.53M CAD
Enterprise Value5.13M CAD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-2.72M CAD
Revenue/Share—
Last Price0.0650 CAD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryDiagnostics & Research
ISINCA87975M2085
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.74
EV/Revenue—
P/S—
P/B-8.33
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.040029% of range0.1250
52W High0.1250 CAD
52W Low0.0400 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-527.93%
ROA-298.34%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.33M CAD
CapEx (TTM)3.25K CAD
FCF Margin—
FCF Yield-6.21%
Net Debt111.19K CAD
Net Debt/EBITDA-0.06
Balance Sheet
Debt/Equity—
Current Ratio0.09
Quick Ratio0.07
Book Value/Sh-0.0060 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 22, 2019
Splits
Last Split1:5
Split DateNov 22, 2019
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.100.43M
Float74.45M
Insiders2.98%
Institutions0.40%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short24.00K
Short (prev mo.)157
Technical
SMA 500.0541 (+20.1%)
SMA 2000.0572 (+13.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)62.06K
Avg Vol (10d)110.48K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—